sglt2 inhibitors vs glp 1 agonists Frontiers Metabolic Powerhouses: GLP-1 RAs and
Description
[DOI] [PubMed] [Google Scholar] 72.Crespel A, et al
Exendin4 exerts osteogenic actions in insulinresistant and type 2 diabetic states
Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity
May have higher risk of GI or metabolic side effects
